Evrofarma SA Net Asset Quality Index
Evrofarma SA net asset quality index. Evrofarma SA (EVROF) has a Net Asset Quality Index of 28.7% as of December 2022. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €48.81 Million minus total liabilities of €34.79 Million yields net assets of €14.03 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Evrofarma SA earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Evrofarma SA (2014–2022)
Net asset quality index of Evrofarma SA from 2014 to 2022. This chart shows how Evrofarma SA's Net Asset Quality Index has evolved across 9 annual periods from 2014 to 2022. As of December 2022, the index stands at 28.7%, representing net assets of €14.03 Million against total assets of €48.81 Million EUR. See EVROF net assets for net asset value and shareholders' equity analysis.
Evrofarma SA Net Asset Quality Index by Year (2014–2022)
Evrofarma SA net asset quality index by year from 2014 to 2022. The table below presents the year-by-year Net Asset Quality Index for Evrofarma SA from 2014 to 2022, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see EVROF company net worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 28.7% | €14.03 Million | €48.81 Million | €34.79 Million | ▲ +1.6 pp |
| 2021 | 27.1% | €12.61 Million | €46.52 Million | €33.91 Million | ▼ -0.8 pp |
| 2020 | 27.9% | €12.95 Million | €46.38 Million | €33.42 Million | ▼ -0.9 pp |
| 2019 | 28.8% | €11.87 Million | €41.20 Million | €29.33 Million | ▲ +2.5 pp |
| 2018 | 26.4% | €11.65 Million | €44.23 Million | €32.58 Million | ▲ +2.6 pp |
| 2017 | 23.8% | €10.73 Million | €45.09 Million | €34.37 Million | ▲ +0.5 pp |
| 2016 | 23.3% | €10.20 Million | €43.75 Million | €33.55 Million | ▲ +1.2 pp |
| 2015 | 22.1% | €9.79 Million | €44.35 Million | €34.55 Million | ▲ +2.5 pp |
| 2014 | 19.6% | €9.27 Million | €47.27 Million | €38.00 Million | — |